Chi Wai Yip

1.4k total citations
36 papers, 718 citations indexed

About

Chi Wai Yip is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Chi Wai Yip has authored 36 papers receiving a total of 718 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Infectious Diseases and 10 papers in Epidemiology. Recurrent topics in Chi Wai Yip's work include Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (7 papers) and Glycosylation and Glycoproteins Research (4 papers). Chi Wai Yip is often cited by papers focused on Tuberculosis Research and Epidemiology (8 papers), Mycobacterium research and diagnosis (7 papers) and Glycosylation and Glycoproteins Research (4 papers). Chi Wai Yip collaborates with scholars based in Hong Kong, China and Japan. Chi Wai Yip's co-authors include ST Cheung, Kai Man Kam, Sheung Tat Fan, Fanya Zeng, Chung-Chau Hon, Phyllis F. Cheung, Tan To Cheung, Linda W.C. Ng, Kwok Hung Chan and Malik Peiris and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Biochemical and Biophysical Research Communications.

In The Last Decade

Chi Wai Yip

35 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi Wai Yip Hong Kong 18 297 236 214 142 128 36 718
Yufeng Yao China 17 182 0.6× 318 1.3× 274 1.3× 70 0.5× 61 0.5× 78 931
Chaka C. Impraim United States 12 102 0.3× 284 1.2× 383 1.8× 68 0.5× 78 0.6× 15 871
Tatiana Pushkarsky United States 19 377 1.3× 161 0.7× 735 3.4× 193 1.4× 175 1.4× 38 1.5k
Zhenghui Wu China 12 301 1.0× 213 0.9× 185 0.9× 25 0.2× 44 0.3× 20 732
Rebecca J. Nusbaum United States 10 215 0.7× 210 0.9× 238 1.1× 170 1.2× 68 0.5× 13 750
Adriana Forero United States 16 288 1.0× 227 1.0× 329 1.5× 27 0.2× 157 1.2× 30 986
Christine Vazquez United States 10 183 0.6× 144 0.6× 583 2.7× 47 0.3× 69 0.5× 26 1.0k
Mercedes Llorente Spain 14 224 0.8× 198 0.8× 244 1.1× 65 0.5× 155 1.2× 18 998
Patrick Labonté Canada 14 124 0.4× 446 1.9× 213 1.0× 140 1.0× 28 0.2× 35 839
Laura Kakkola Finland 19 453 1.5× 241 1.0× 443 2.1× 47 0.3× 81 0.6× 48 1.4k

Countries citing papers authored by Chi Wai Yip

Since Specialization
Citations

This map shows the geographic impact of Chi Wai Yip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Wai Yip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Wai Yip more than expected).

Fields of papers citing papers by Chi Wai Yip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Wai Yip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Wai Yip. The network helps show where Chi Wai Yip may publish in the future.

Co-authorship network of co-authors of Chi Wai Yip

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Wai Yip. A scholar is included among the top collaborators of Chi Wai Yip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Wai Yip. Chi Wai Yip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dileep, K.V., Naoki Sakai, Kentaro Ihara, et al.. (2024). Identification of benzimidazole-6-carboxamide based inhibitors of secretory glutaminyl cyclase for the treatment of Alzheimer's disease. International Journal of Biological Macromolecules. 293. 139320–139320.
2.
Haberman, Nejc, Rupert Faraway, Anob M. Chakrabarti, et al.. (2024). Widespread 3′UTR capped RNAs derive from G-rich regions in proximity to AGO2 binding sites. BMC Biology. 22(1). 254–254. 2 indexed citations
3.
Cheung, Phyllis F., Chi Wai Yip, Linda W.C. Ng, et al.. (2019). The ATP-binding cassette transporter ABCF1 is a hepatic oncofetal protein that promotes chemoresistance, EMT and cancer stemness in hepatocellular carcinoma. Cancer Letters. 457. 98–109. 48 indexed citations
4.
Yip, Chi Wai, et al.. (2018). Mouse Monoclonal Antibodies Against Progranulin (PGRN/GEP) as Therapeutics in Preclinical Cancer Models. Methods in molecular biology. 1806. 131–144. 1 indexed citations
5.
Cheung, Phyllis F., Chi Wai Yip, Linda W.C. Ng, et al.. (2016). Comprehensive characterization of the patient-derived xenograft and the paralleled primary hepatocellular carcinoma cell line. Cancer Cell International. 16(1). 41–41. 15 indexed citations
6.
Lo, Kwok Wai, Chi Wai Yip, Tan To Cheung, et al.. (2015). Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer. BMC Cancer. 15(1). 264–264. 6 indexed citations
7.
Cheung, Phyllis F., Chi Wai Yip, Nicholas Wong, et al.. (2014). Granulin–Epithelin Precursor Renders Hepatocellular Carcinoma Cells Resistant to Natural Killer Cytotoxicity. Cancer Immunology Research. 2(12). 1209–1219. 37 indexed citations
8.
Wong, Nicholas C.L., Phyllis F. Cheung, Chi Wai Yip, et al.. (2014). Antibody against Granulin–Epithelin Precursor Sensitizes Hepatocellular Carcinoma to Chemotherapeutic Agents. Molecular Cancer Therapeutics. 13(12). 3001–3012. 26 indexed citations
9.
Kam, Kai Man, Chi Wai Yip, Wing Wai Yew, et al.. (2014). Concurrent Outbreaks of Tuberculosis in a School and the Wider Community in Macau. Journal of the Pediatric Infectious Diseases Society. 4(4). 359–362. 2 indexed citations
10.
Yip, Chi Wai, et al.. (2014). Granulin-epithelin precursor interacts with heparan sulfate on liver cancer cells. Carcinogenesis. 35(11). 2485–2494. 14 indexed citations
11.
Yip, Chi Wai, Terence C. W. Poon, Eddy Wing Yin Ng, et al.. (2012). Identification and Characterization of Tropomyosin 3 Associated with Granulin-Epithelin Precursor in Human Hepatocellular Carcinoma. PLoS ONE. 7(7). e40324–e40324. 26 indexed citations
12.
Yip, Chi Wai, et al.. (2012). Random blinded rechecking of sputum acid-fast bacilli smear using fluorescence microscopy: 8 years' experience. The International Journal of Tuberculosis and Lung Disease. 16(3). 398–401. 4 indexed citations
13.
Yip, Chi Wai, et al.. (2012). Cell culture-adapted IBDV uses endocytosis for entry in DF-1 chicken embryonic fibroblasts. Virus Research. 165(1). 9–16. 22 indexed citations
14.
15.
16.
Zeng, Fanya, Ken Y.C. Chow, Chung-Chau Hon, et al.. (2004). Characterization of humoral responses in mice immunized with plasmid DNAs encoding SARS-CoV spike gene fragments. Biochemical and Biophysical Research Communications. 315(4). 1134–1139. 50 indexed citations
17.
Kam, Kai Man, et al.. (2002). Trends in Multidrug‐ResistantMycobacterium tuberculosisin Relation to Sputum Smear Positivity in Hong Kong, 1989–1999. Clinical Infectious Diseases. 34(3). 324–329. 3 indexed citations
18.
Kam, Kai Man, et al.. (1999). IS6110 dot blot hybridization for the identification of Mycobacterium tuberculosis complex. Diagnostic Microbiology and Infectious Disease. 33(1). 13–18. 3 indexed citations
19.
Yip, Chi Wai, et al.. (1994). Occurrence of genetic segregation in a putative haploid strain of Endomyces fibuliger met by spontaneous sectoring of protoplast fusants. World Journal of Microbiology and Biotechnology. 10(4). 465–471. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yufeng Yao Breakdown of academic impact, for papers by Chaka C. Impraim Breakdown of academic impact, for papers by Tatiana Pushkarsky Breakdown of academic impact, for papers by Zhenghui Wu Breakdown of academic impact, for papers by Rebecca J. Nusbaum Breakdown of academic impact, for papers by Adriana Forero Breakdown of academic impact, for papers by Christine Vazquez Breakdown of academic impact, for papers by Mercedes Llorente Breakdown of academic impact, for papers by Patrick Labonté Breakdown of academic impact, for papers by Laura Kakkola
Rankless by CCL
2026